\-\ Texto\\:\\ \ \(0\)\
\-\ vital\\ signs\\:\\ \ \(0\)\
\-\ t\\-36\\.8\\ \ \(0\)\
\-\ p\\-81\ \(0\)\
\-\ rr\\-18\ \(0\)\
\-\ bp\\-125\\/72\ \(0\)\
\-\ bmi\\-33\\.2\ \(0\)\
\-\ physical\\ exam\\:\ \(1\)\
\-\ general\\-nad\\,\\ female\\ who\\ appears\\ stated\\ age\ \(0\)\
\-\ chest\\-rrr\\,\\ clear\\ to\\ auscultation\\ bilaterally\ \(0\)\
\-\ abdomen\\-soft\\,\\ non\\-tender\\,\\ non\\-distended\\.\\ no\\ cva\\ tenderness\ \(0\)\
\-\ extremities\\-no\\ cyanosis\\,\\ clubbing\\,\\ or\\ edema\ \(0\)\
\-\ neuro\\-no\\ focal\\ deficits\ \(0\)\
\-\ skin\\-no\\ skin\\ rash\\ or\\ skin\\ lesion\ \(0\)\
\-\ msk\\-normal\\ muscle\\ strength\\ and\\ tone\ \(0\)\
\-\ labs\\:\\ \ \(3\)\
\-\ ua\\-rbcs\\ 3\\-5\\ per\\ hpf\\.\\ trace\\ bacteria\\.\\ \ \(0\)\
\-\ urine\\ cytology\\-negative\ \(0\)\
\-\ wbc\\-5\\.9\ \(0\)\
\-\ hgb\\-15\\.1\ \(0\)\
\-\ platelets\\-193\ \(0\)\
\-\ interventional\\ radiology\\ was\\ consulted\\.\\ the\\ believed\\ diagnosis\\ based\\ on\\ the\\ ct\\ findings\\ was\\ conveyed\\ to\\ the\\ patient\\ and\\ a\\ decision\\ was\\ made\\ to\\ proceed\\ with\\ a\\ left\\ renal\\ angiogram\\ to\\ confirm\\ the\\ diagnosis\\ and\\ to\\ attempt\\ to\\ embolization\\ of\\ the\\ arteriovenous\\ fistula\\.\\ the\\ left\\ renal\\ angiogram\\ confirmed\\ the\\ diagnosis\\ as\\ mentioned\\ previously\\.\\ \\ attempt\\ at\\ embolization\\ of\\ the\\ distal\\ branch\\ of\\ the\\ left\\ renal\\ artery\\ with\\ detachable\\ coils\\ failed\\ multiple\\ attempts\\ due\\ to\\ high\\ flow\\ across\\ the\\ fistula\\.\\ the\\ decision\\ was\\ made\\ to\\ stop\\ the\\ procedure\\.\\ shortly\\ after\\ the\\ procedure\\ the\\ team\\ in\\ coordination\\ with\\ the\\ patient\\ and\\ her\\ family\\ decided\\ not\\ to\\ pursue\\ another\\ attempt\\ as\\ she\\ remained\\ asymptomatic\\.\ \(0\)\
\-\ ct\\ abdomen\\ with\\ and\\ without\\ contrast\\ using\\ angiogram\\ and\\ venogram\\ protocol\\:\ \(0\)\
\-\ arterial\\ phase\\ of\\ the\\ study\\ demonstrates\\ a\\ posterior\\ branch\\ of\\ the\\ left\\ renal\\ artery\\ ending\\ as\\ a\\ large\\ \\(5\\ cm\\ x\\ 4\\ cm\\)\\ aneurysm\\ like\\ dilatation\\ at\\ the\\ renal\\ hilum\\ which\\ in\\ turn\\ empties\\ more\\ anteriorly\\ through\\ a\\ narrowing\\ \\(about\\ 0\\.2\\ cm\\)\\ into\\ a\\ renal\\ vein\\ tributary\\.\ \(0\)\
\-\ left\\ renal\\ arteriovenous\\ fistula\ \(0\)\
\-\ renal\\ cell\\ carcinoma\\/tumor\ \(0\)\
\-\ cystic\\ disease\ \(15\)\
\-\ ateriovenous\\ malformation\ \(1\)\
\-\ a\\-v\\ fistula\ \(0\)\
\-\ 56\\ y\\.o\\.\\ woman\\ presented\\ to\\ an\\ outside\\ urology\\ service\\ after\\ she\\ was\\ found\\ to\\ have\\ microscopic\\ hematuria\\ on\\ a\\ routine\\ evaluation\\.\\ she\\ denies\\ any\\ history\\ of\\ flank\\ pain\\,\\ \\ renal\\ surgery\\,\\ or\\ trauma\\.\\ patient\\ does\\ not\\ smoke\\.\\ patient\\ was\\ evaluated\\ via\\ cytoscopy\\ which\\ was\\ negative\\.\\ cytology\\ was\\ sent\\ for\\ malignant\\ cells\\ which\\ was\\ negative\\ as\\ well\\.\\ ct\\ abdomen\\ was\\ done\\ which\\ demonstrated\\ a\\ left\\ renal\\ abnormality\\.\\ further\\ imaging\\ was\\ then\\ obtained\\.\\ \ \(0\)\
\-\ pmhx\\:\\ htn\\,\\ sleep\\ apnea\ \(0\)\
\-\ medication\\:\\ lisinopril\\ 10\\ mg\\ daily\ \(0\)\
\-\ a\\ renal\\ arteriovenous\\ fistula\\ \\(avf\\)\\ is\\ a\\ relatively\\ rare\\ diagnosis\\ especially\\ in\\ a\\ patient\\ such\\ as\\ ours\\ who\\ has\\ not\\ undergone\\ any\\ previous\\ renal\\ procedures\\ or\\ trauma\\.\\ taking\\ this\\ history\\ into\\ account\\ the\\ patient\\â\\€\\™s\\ etiology\\ is\\ mostly\\ likely\\ idiopathic\\ which\\ is\\ the\\ case\\ in\\ less\\ than\\ 5\\%\\ of\\ all\\ renal\\ avfs\\.\\ patients\\ with\\ renal\\ avfs\\ often\\ present\\ with\\ microscopic\\ hematuria\\â\\€\\”as\\ our\\ patient\\ did\\â\\€\\”but\\ may\\ also\\ present\\ with\\ gross\\ hematuria\\,\\ symptoms\\ of\\ congestive\\ heart\\ failure\\,\\ and\\ hypertension\\.\\ the\\ gold\\ standard\\ for\\ diagnosis\\ of\\ avf\\ is\\ angiography\\ which\\ is\\ invasive\\ yet\\ warranted\\ in\\ a\\ patient\\ who\\ is\\ clearly\\ symptomatic\\ and\\ will\\ need\\ intervention\\.\\ \\ however\\,\\ a\\ noninvasive\\ imaging\\ modality\\ such\\ as\\ dynamic\\ ct\\ could\\ be\\ an\\ alternative\\ diagnostic\\ tool\\ for\\ patients\\ in\\ whom\\ invasive\\ intervention\\ is\\ not\\ necessary\\ or\\ contraindicated\\.\\ dynamic\\ ct\\,\\ in\\ particular\\,\\ is\\ beneficial\\ in\\ this\\ case\\ because\\ we\\ can\\ visualize\\ injected\\ contrast\\ during\\ two\\ distinct\\ phases\\ of\\ blood\\ flow\\:\\ arterial\\ phase\\ and\\ venous\\ phase\\.\\ \\ in\\ our\\ case\\ the\\ patient\\â\\€\\™s\\ dynamic\\ ct\\ demonstrated\\ early\\ opacification\\ of\\ the\\ left\\ renal\\ vein\\ in\\ images\\ taken\\ during\\ the\\ arterial\\ phase\\ suggesting\\ that\\ there\\ was\\ a\\ direct\\ connection\\ between\\ the\\ renal\\ arterial\\ and\\ venous\\ system\\ allowing\\ contrast\\ to\\ enter\\ the\\ venous\\ system\\ before\\ it\\ should\\ have\\.\\ our\\ patient\\ did\\ have\\ an\\ angiogram\\ done\\ to\\ confirm\\ the\\ diagnosis\\ during\\ interventional\\ radiology\\â\\€\\™s\\ attempt\\ to\\ embolize\\ the\\ vascular\\ defect\\.\\ however\\,\\ if\\ the\\ decision\\ had\\ been\\ made\\ for\\ conservative\\ expectant\\ management\\,\\ the\\ team\\ would\\ have\\ felt\\ confident\\ in\\ the\\ diagnosis\\ obtained\\ via\\ dynamic\\ ct\\ rather\\ than\\ subjecting\\ the\\ patient\\ to\\ the\\ invasive\\ gold\\ standard\\ angiogram\\.\\ \ \(0\)\
\-\ reference\\:\ \(0\)\
\-\ d\\Ã\\¶nmez\\,\\ fuldem\\ et\\ al\\.\\ \\\\"noninvasive\\ imaging\\ findings\\ of\\ idiopathic\\ renal\\ arteriovenous\\ fistula\\.\\\\"\\ diagnostic\\ and\\ interventional\\ radiology\\.\\ 14\\.2\\ \\(2008\\)\\:\\ 103\\-105\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ renal\\:\\ 0\\.06553616267385462\ \(0\)\
\-\ dynamic\\:\\ 0\\.03315124058836138\ \(0\)\
\-\ fistula\\:\\ 0\\.03146055263274945\ \(0\)\
\-\ angiogram\\:\\ 0\\.031031435411728817\ \(0\)\
\-\ attempt\\:\\ 0\\.029450422934164274\ \(0\)\
\-\ arteriovenous\\:\\ 0\\.02693564614822923\ \(0\)\
\-\ decision\\:\\ 0\\.02503343191867124\ \(0\)\
\-\ avfs\\:\\ 0\\.024391505235455115\ \(0\)\
\-\ phase\\:\\ 0\\.02414250977999854\ \(0\)\
\-\ interventional\\:\\ 0\\.023092968332669196\ \(0\)\
\-\ arterial\\:\\ 0\\.022464532184580607\ \(0\)\
\-\ diagnosis\\:\\ 0\\.020623926900094503\ \(0\)\
\-\ noninvasive\\:\\ 0\\.019874756296187023\ \(0\)\
\-\ invasive\\:\\ 0\\.019341125436565125\ \(0\)\
\-\ avf\\:\\ 0\\.018547931214267985\ \(0\)\
\-\ our\\:\\ 0\\.018296974021892495\ \(0\)\
\-\ was\\:\\ 0\\.01780680220204841\ \(0\)\
\-\ gold\\:\\ 0\\.016929323103959615\ \(0\)\
\-\ microscopic\\:\\ 0\\.01636102881075082\ \(0\)\
\-\ radiology\\:\\ 0\\.016268070886890553\ \(0\)\
\-\ team\\:\\ 0\\.015395312221779464\ \(0\)\
\-\ made\\:\\ 0\\.015332758432934497\ \(0\)\
\-\ \\:\\:\\ 0\\.015273983999873854\ \(0\)\
\-\ which\\:\\ 0\\.014370671957140079\ \(0\)\
\-\ patient\\:\\ 0\\.014147914774895297\ \(0\)\
\-\ venous\\:\\ 0\\.013972007290347428\ \(0\)\
\-\ branch\\:\\ 0\\.013891482528348565\ \(0\)\
\-\ t\\-36\\.8\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ p\\-81\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ rr\\-18\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ bp\\-125\\/72\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ bmi\\-33\\.2\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ general\\-nad\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ chest\\-rrr\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ abdomen\\-soft\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ extremities\\-no\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ neuro\\-no\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ skin\\-no\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ msk\\-normal\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ ua\\-rbcs\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ cytology\\-negative\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ wbc\\-5\\.9\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ hgb\\-15\\.1\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ platelets\\-193\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ conveyed\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ carcinoma\\/tumor\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ cytoscopy\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ hematuria\\â\\€\\”as\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ did\\â\\€\\”but\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ confident\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ subjecting\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ d\\Ã\\¶nmez\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ fuldem\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ fistula\\.\\\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ 103\\-105\\:\\ 0\\.013236514150099847\ \(0\)\
\-\ standard\\:\\ 0\\.013131733235664208\ \(0\)\
\-\ confirm\\:\\ 0\\.013061892808744488\ \(0\)\
\-\ ct\\:\\ 0\\.01256325161222868\ \(0\)\
\-\ hpf\\:\\ 0\\.012195752617727557\ \(0\)\
\-\ tributary\\:\\ 0\\.012195752617727557\ \(0\)\
\-\ ours\\:\\ 0\\.012195752617727557\ \(0\)\
\-\ 14\\.2\\:\\ 0\\.012195752617727557\ \(0\)\
\-\ hematuria\\:\\ 0\\.012172205673179405\ \(0\)\
\-\ embolization\\:\\ 0\\.011949659210255316\ \(0\)\
\-\ during\\:\\ 0\\.011779320945602738\ \(0\)\
\-\ idiopathic\\:\\ 0\\.01169831080522034\ \(0\)\
\-\ as\\:\\ 0\\.011644842395442593\ \(0\)\
\-\ ateriovenous\\:\\ 0\\.011586946149096678\ \(0\)\
\-\ \\\\:\\ 0\\.011586946149096678\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.01150462495335791\ \(0\)\
\-\ intervention\\:\\ 0\\.011426075465075803\ \(0\)\
\-\ detachable\\:\\ 0\\.011154991085355266\ \(0\)\
\-\ a\\-v\\:\\ 0\\.011154991085355266\ \(0\)\
\-\ embolize\\:\\ 0\\.011154991085355266\ \(0\)\
\-\ have\\:\\ 0\\.011113742212402954\ \(0\)\
\-\ s\\:\\ 0\\.011039493996011653\ \(0\)\
\-\ via\\:\\ 0\\.011015086928387523\ \(0\)\
\-\ she\\:\\ 0\\.010805342979523298\ \(0\)\
\-\ procedure\\:\\ 0\\.010747977360770418\ \(0\)\
\-\ done\\:\\ 0\\.010638194790999254\ \(0\)\
\-\ expectant\\:\\ 0\\.010546184616724389\ \(0\)\
\-\ cm\\:\\ 0\\.01032412665683327\ \(0\)\
\-\ empties\\:\\ 0\\.010314727139506284\ \(0\)\
\-\ diagnostic\\:\\ 0\\.01016868707210828\ \(0\)\
\-\ lisinopril\\:\\ 0\\.010114229552982976\ \(0\)\
\-\ system\\:\\ 0\\.01010354345465705\ \(0\)\
\-\ left\\:\\ 0\\.010049154481847454\ \(0\)\
\-\ who\\:\\ 0\\.010035893734872531\ \(0\)\
\-\ proceed\\:\\ 0\\.009937378148093512\ \(0\)\
\-\ whom\\:\\ 0\\.009937378148093512\ \(0\)\
\-\ skin\\:\\ 0\\.009856243048765699\ \(0\)\
\-\ pursue\\:\\ 0\\.009779179175634313\ \(0\)\
\-\ tool\\:\\ 0\\.009779179175634313\ \(0\)\
\-\ to\\:\\ 0\\.009618651091058248\ \(0\)\
\-\ smoke\\:\\ 0\\.009505423084352099\ \(0\)\
\-\ vein\\:\\ 0\\.009285085051093446\ \(0\)\
\-\ 3\\-5\\:\\ 0\\.009273965607133993\ \(0\)\
\-\ beneficial\\:\\ 0\\.009273965607133993\ \(0\)\
\-\ obtained\\:\\ 0\\.00912272102325478\ \(0\)\
\-\ contraindicated\\:\\ 0\\.009073468020610686\ \(0\)\
\-\ imaging\\:\\ 0\\.009018350560610823\ \(0\)\
\-\ venogram\\:\\ 0\\.008982440059925349\ \(0\)\
\-\ enter\\:\\ 0\\.008982440059925349\ \(0\)\
\-\ coordination\\:\\ 0\\.008896616615721222\ \(0\)\
\-\ apnea\\:\\ 0\\.008896616615721222\ \(0\)\
\-\ ending\\:\\ 0\\.008815434601801888\ \(0\)\
\-\ attempts\\:\\ 0\\.008738417643262022\ \(0\)\
\-\ alternative\\:\\ 0\\.008738417643262022\ \(0\)\
\-\ cva\\:\\ 0\\.008665159138503116\ \(0\)\
\-\ cytology\\:\\ 0\\.008665159138503116\ \(0\)\
\-\ contrast\\:\\ 0\\.008616106697332907\ \(0\)\
\-\ turn\\:\\ 0\\.00859530926517745\ \(0\)\
\-\ 0\\.2\\:\\ 0\\.00859530926517745\ \(0\)\
\-\ stop\\:\\ 0\\.008528564876932956\ \(0\)\
\-\ undergone\\:\\ 0\\.008528564876932956\ \(0\)\
\-\ flow\\:\\ 0\\.008480642272848397\ \(0\)\
\-\ trace\\:\\ 0\\.008464661551979807\ \(0\)\
\-\ case\\:\\ 0\\.00842119113904176\ \(0\)\
\-\ phases\\:\\ 0\\.00840336726591336\ \(0\)\
\-\ decided\\:\\ 0\\.008344477306223747\ \(0\)\
\-\ a\\:\\ 0\\.00833693277096159\ \(0\)\
\-\ allowing\\:\\ 0\\.008287810147090345\ \(0\)\
\-\ coils\\:\\ 0\\.00818051440537541\ \(0\)\
\-\ bacteria\\:\\ 0\\.008129611174631145\ \(0\)\
\-\ warranted\\:\\ 0\\.008129611174631145\ \(0\)\
\-\ any\\:\\ 0\\.008080585684901782\ \(0\)\
\-\ non\\-distended\\:\\ 0\\.008032706488238395\ \(0\)\
\-\ such\\:\\ 0\\.00802202038991247\ \(0\)\
\-\ visualize\\:\\ 0\\.007986502796546573\ \(0\)\
\-\ clubbing\\:\\ 0\\.007941678527553057\ \(0\)\
\-\ urology\\:\\ 0\\.007941678527553057\ \(0\)\
\-\ congestive\\:\\ 0\\.007941678527553057\ \(0\)\
\-\ injected\\:\\ 0\\.007941678527553057\ \(0\)\
\-\ connection\\:\\ 0\\.00789815369741304\ \(0\)\
\-\ rash\\:\\ 0\\.007814715482465876\ \(0\)\
\-\ consulted\\:\\ 0\\.007814715482465876\ \(0\)\
\-\ hilum\\:\\ 0\\.007735670837592871\ \(0\)\
\-\ believed\\:\\ 0\\.007697656110889732\ \(0\)\
\-\ negative\\:\\ 0\\.007664024508633256\ \(0\)\
\-\ mentioned\\:\\ 0\\.007660580116009294\ \(0\)\
\-\ artery\\:\\ 0\\.007641231207532129\ \(0\)\
\-\ distinct\\:\\ 0\\.007624397606130825\ \(0\)\
\-\ abdomen\\:\\ 0\\.00760175454323032\ \(0\)\
\-\ pmhx\\:\\ 0\\.007589066528938341\ \(0\)\
\-\ demonstrated\\:\\ 0\\.00752978973710801\ \(0\)\
\-\ cyanosis\\:\\ 0\\.0075208047060002685\ \(0\)\
\-\ or\\:\\ 0\\.007518939556784591\ \(0\)\
\-\ 5\\:\\ 0\\.0075079892565890795\ \(0\)\
\-\ mostly\\:\\ 0\\.007487803344560665\ \(0\)\
\-\ service\\:\\ 0\\.0074239000196075185\ \(0\)\
\-\ 2008\\:\\ 0\\.0074239000196075185\ \(0\)\
\-\ not\\:\\ 0\\.007416328358810423\ \(0\)\
\-\ shortly\\:\\ 0\\.0073037157738514566\ \(0\)\
\-\ sleep\\:\\ 0\\.007275114880502067\ \(0\)\
\-\ account\\:\\ 0\\.007247048614718054\ \(0\)\
\-\ tone\\:\\ 0\\.007192442542389412\ \(0\)\
\-\ yet\\:\\ 0\\.007192442542389412\ \(0\)\
\-\ failed\\:\\ 0\\.007165866600798721\ \(0\)\
\-\ however\\:\\ 0\\.007145249416207419\ \(0\)\
\-\ htn\\:\\ 0\\.007064030870560341\ \(0\)\
\-\ mg\\:\\ 0\\.007039615674056166\ \(0\)\
\-\ modality\\:\\ 0\\.007039615674056166\ \(0\)\
\-\ trauma\\:\\ 0\\.00701804438966345\ \(0\)\
\-\ stated\\:\\ 0\\.006991944955866105\ \(0\)\
\-\ remained\\:\\ 0\\.006991944955866105\ \(0\)\
\-\ in\\:\\ 0\\.0069600143116258315\ \(0\)\
\-\ procedures\\:\\ 0\\.006945741264174282\ \(0\)\
\-\ \\,\\:\\ 0\\.006910016687378206\ \(0\)\
\-\ protocol\\:\\ 0\\.006900916995180768\ \(0\)\
\-\ reference\\:\\ 0\\.006900916995180768\ \(0\)\
\-\ particular\\:\\ 0\\.006878996875929788\ \(0\)\
\-\ across\\:\\ 0\\.006857392165040749\ \(0\)\
\-\ the\\:\\ 0\\.006850189782612089\ \(0\)\
\-\ taking\\:\\ 0\\.006815093550976641\ \(0\)\
\-\ non\\-tender\\:\\ 0\\.0067943828570842454\ \(0\)\
\-\ opacification\\:\\ 0\\.0067943828570842454\ \(0\)\
\-\ is\\:\\ 0\\.006754243584200908\ \(0\)\
\-\ 56\\:\\ 0\\.006753799264910192\ \(0\)\
\-\ we\\:\\ 0\\.006753799264910192\ \(0\)\
\-\ than\\:\\ 0\\.0067238704351900115\ \(0\)\
\-\ patients\\:\\ 0\\.006641365163261339\ \(0\)\
\-\ daily\\:\\ 0\\.006638242146087176\ \(0\)\
\-\ clearly\\:\\ 0\\.006601618342597448\ \(0\)\
\-\ auscultation\\:\\ 0\\.006530946404372244\ \(0\)\
\-\ sent\\:\\ 0\\.006530946404372244\ \(0\)\
\-\ medication\\:\\ 0\\.006463451828002475\ \(0\)\
\-\ angiography\\:\\ 0\\.006447041812188375\ \(0\)\
\-\ need\\:\\ 0\\.006398861159708645\ \(0\)\
\-\ anteriorly\\:\\ 0\\.00629211052654989\ \(0\)\
\-\ suggesting\\:\\ 0\\.0062343533481297765\ \(0\)\
\-\ urine\\:\\ 0\\.006192448260866899\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.006185433939886615\ \(0\)\
\-\ vital\\:\\ 0\\.006138334242123359\ \(0\)\
\-\ gross\\:\\ 0\\.006111991434839712\ \(0\)\
\-\ into\\:\\ 0\\.006106085189068189\ \(0\)\
\-\ rather\\:\\ 0\\.0060989913406308315\ \(0\)\
\-\ direct\\:\\ 0\\.006060653049331784\ \(0\)\
\-\ flank\\:\\ 0\\.006035627444999635\ \(0\)\
\-\ felt\\:\\ 0\\.006035627444999635\ \(0\)\
\-\ like\\:\\ 0\\.005939498527935174\ \(0\)\
\-\ evaluated\\:\\ 0\\.00588240033635974\ \(0\)\
\-\ deficits\\:\\ 0\\.0058712367049971\ \(0\)\
\-\ present\\:\\ 0\\.005795822083878921\ \(0\)\
\-\ strength\\:\\ 0\\.005693150004685018\ \(0\)\
\-\ necessary\\:\\ 0\\.005683304057919013\ \(0\)\
\-\ per\\:\\ 0\\.005616133046145152\ \(0\)\
\-\ using\\:\\ 0\\.00556992935445333\ \(0\)\
\-\ another\\:\\ 0\\.005516298599795553\ \(0\)\
\-\ dilatation\\:\\ 0\\.005498839083286365\ \(0\)\
\-\ relatively\\:\\ 0\\.0054901848719999535\ \(0\)\
\-\ findings\\:\\ 0\\.005461972780150029\ \(0\)\
\-\ al\\:\\ 0\\.005439281641255687\ \(0\)\
\-\ etiology\\:\\ 0\\.005430963052103112\ \(0\)\
\-\ before\\:\\ 0\\.005430963052103112\ \(0\)\
\-\ denies\\:\\ 0\\.005414462869557173\ \(0\)\
\-\ previously\\:\\ 0\\.005390047673052999\ \(0\)\
\-\ outside\\:\\ 0\\.005381996707375243\ \(0\)\
\-\ taken\\:\\ 0\\.005350217711591394\ \(0\)\
\-\ an\\:\\ 0\\.00532281470398527\ \(0\)\
\-\ after\\:\\ 0\\.005309312920748356\ \(0\)\
\-\ especially\\:\\ 0\\.005281082668796489\ \(0\)\
\-\ family\\:\\ 0\\.005258727394781848\ \(0\)\
\-\ et\\:\\ 0\\.0052513489941776\ \(0\)\
\-\ narrowing\\:\\ 0\\.005144814856081077\ \(0\)\
\-\ routine\\:\\ 0\\.005144814856081077\ \(0\)\
\-\ cells\\:\\ 0\\.005144814856081077\ \(0\)\
\-\ conservative\\:\\ 0\\.005124385949090419\ \(0\)\
\-\ malformation\\:\\ 0\\.0051176376163759455\ \(0\)\
\-\ symptomatic\\:\\ 0\\.005097572709751069\ \(0\)\
\-\ aneurysm\\:\\ 0\\.005071229902467421\ \(0\)\
\-\ hypertension\\:\\ 0\\.005058229808258541\ \(0\)\
\-\ failure\\:\\ 0\\.005026213637884935\ \(0\)\
\-\ rare\\:\\ 0\\.00498250780581576\ \(0\)\
\-\ previous\\:\\ 0\\.00498250780581576\ \(0\)\
\-\ about\\:\\ 0\\.0049460322914478255\ \(0\)\
\-\ based\\:\\ 0\\.004892928471872313\ \(0\)\
\-\ management\\:\\ 0\\.004841638803987449\ \(0\)\
\-\ confirmed\\:\\ 0\\.0048249243289591555\ \(0\)\
\-\ defect\\:\\ 0\\.004802923913363253\ \(0\)\
\-\ appears\\:\\ 0\\.004775869100296169\ \(0\)\
\-\ clear\\:\\ 0\\.004744033953673642\ \(0\)\
\-\ abnormality\\:\\ 0\\.00473357048623206\ \(0\)\
\-\ could\\:\\ 0\\.00473357048623206\ \(0\)\
\-\ early\\:\\ 0\\.004692430885349006\ \(0\)\
\-\ malignant\\:\\ 0\\.004637643658227179\ \(0\)\
\-\ did\\:\\ 0\\.0046327607222115975\ \(0\)\
\-\ muscle\\:\\ 0\\.004608581431571088\ \(0\)\
\-\ then\\:\\ 0\\.004566016333967101\ \(0\)\
\-\ would\\:\\ 0\\.004566016333967101\ \(0\)\
\-\ signs\\:\\ 0\\.0045155794804595415\ \(0\)\
\-\ because\\:\\ 0\\.004488766241120192\ \(0\)\
\-\ labs\\:\\ 0\\.004462423433836544\ \(0\)\
\-\ heart\\:\\ 0\\.004458077550914075\ \(0\)\
\-\ for\\:\\ 0\\.004379027919776067\ \(0\)\
\-\ does\\:\\ 0\\.004377809414991001\ \(0\)\
\-\ less\\:\\ 0\\.004345255261745769\ \(0\)\
\-\ \\(\\:\\ 0\\.004338508866329493\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.0043372258228169475\ \(0\)\
\-\ 10\\:\\ 0\\.00432526160412449\ \(0\)\
\-\ \\)\\:\\ 0\\.004285511664344175\ \(0\)\
\-\ x\\:\\ 0\\.004232832335356572\ \(0\)\
\-\ study\\:\\ 0\\.004221668703993932\ \(0\)\
\-\ bilaterally\\:\\ 0\\.004214272129915771\ \(0\)\
\-\ vascular\\:\\ 0\\.004206911813699244\ \(0\)\
\-\ often\\:\\ 0\\.004093804126906385\ \(0\)\
\-\ should\\:\\ 0\\.004090403216049249\ \(0\)\
\-\ further\\:\\ 0\\.004080246459159546\ \(0\)\
\-\ between\\:\\ 0\\.004066810114450817\ \(0\)\
\-\ found\\:\\ 0\\.00404358200368185\ \(0\)\
\-\ will\\:\\ 0\\.004014235763332045\ \(0\)\
\-\ age\\:\\ 0\\.0039052707590755352\ \(0\)\
\-\ tenderness\\:\\ 0\\.0039022707550775276\ \(0\)\
\-\ her\\:\\ 0\\.003857975463190594\ \(0\)\
\-\ evaluation\\:\\ 0\\.0037270852790192307\ \(0\)\
\-\ y\\.o\\:\\ 0\\.0037032724213013515\ \(0\)\
\-\ cystic\\:\\ 0\\.0037006497105882257\ \(0\)\
\-\ two\\:\\ 0\\.0036746715279519604\ \(0\)\
\-\ focal\\:\\ 0\\.0036644048110186216\ \(0\)\
\-\ through\\:\\ 0\\.0036440796072385413\ \(0\)\
\-\ edema\\:\\ 0\\.0036290142483953315\ \(0\)\
\-\ all\\:\\ 0\\.0036290142483953315\ \(0\)\
\-\ likely\\:\\ 0\\.003619054002906391\ \(0\)\
\-\ 4\\:\\ 0\\.003575032890659227\ \(0\)\
\-\ history\\:\\ 0\\.003544187800922172\ \(0\)\
\-\ high\\:\\ 0\\.0035113304220372606\ \(0\)\
\-\ blood\\:\\ 0\\.0035021187274914406\ \(0\)\
\-\ presented\\:\\ 0\\.003497533986520134\ \(0\)\
\-\ been\\:\\ 0\\.0034906830172132\ \(0\)\
\-\ distal\\:\\ 0\\.003488406289708749\ \(0\)\
\-\ if\\:\\ 0\\.0034815967474183715\ \(0\)\
\-\ at\\:\\ 0\\.0034767662247196184\ \(0\)\
\-\ cell\\:\\ 0\\.003465826894266496\ \(0\)\
\-\ due\\:\\ 0\\.0034238395689982575\ \(0\)\
\-\ more\\:\\ 0\\.003208973437405655\ \(0\)\
\-\ symptoms\\:\\ 0\\.0031976838992464553\ \(0\)\
\-\ physical\\:\\ 0\\.0031479058101820394\ \(0\)\
\-\ surgery\\:\\ 0\\.0031156142107511635\ \(0\)\
\-\ without\\:\\ 0\\.0030210407903275677\ \(0\)\
\-\ \\%\\:\\ 0\\.002992974524543555\ \(0\)\
\-\ and\\:\\ 0\\.002973121716297902\ \(0\)\
\-\ woman\\:\\ 0\\.002963818239472832\ \(0\)\
\-\ posterior\\:\\ 0\\.002957415238291965\ \(0\)\
\-\ can\\:\\ 0\\.0029102437724760804\ \(0\)\
\-\ well\\:\\ 0\\.002902523953406383\ \(0\)\
\-\ this\\:\\ 0\\.0028862979378802794\ \(0\)\
\-\ it\\:\\ 0\\.002884156733533058\ \(0\)\
\-\ exam\\:\\ 0\\.002818669579503811\ \(0\)\
\-\ may\\:\\ 0\\.002814306860207393\ \(0\)\
\-\ large\\:\\ 0\\.002805619267013633\ \(0\)\
\-\ demonstrates\\:\\ 0\\.002802734537016796\ \(0\)\
\-\ had\\:\\ 0\\.0027685432721331954\ \(0\)\
\-\ multiple\\:\\ 0\\.002702411416635539\ \(0\)\
\-\ female\\:\\ 0\\.0026377781853571076\ \(0\)\
\-\ lesion\\:\\ 0\\.0026134462852859678\ \(0\)\
\-\ also\\:\\ 0\\.0025294588493545815\ \(0\)\
\-\ images\\:\\ 0\\.0024613571951191504\ \(0\)\
\-\ has\\:\\ 0\\.0024094594151565733\ \(0\)\
\-\ that\\:\\ 0\\.0022161872801183535\ \(0\)\
\-\ on\\:\\ 0\\.0021738468839802645\ \(0\)\
\-\ of\\:\\ 0\\.0020991675819457376\ \(0\)\
\-\ disease\\:\\ 0\\.002097203515338895\ \(0\)\
\-\ be\\:\\ 0\\.0019786136987146085\ \(0\)\
\-\ there\\:\\ 0\\.001909482817514998\ \(0\)\
\-\ \\.\\:\\ 0\\.0015990782025831654\ \(0\)\
\-\ pain\\:\\ 0\\.0015669792305266286\ \(0\)\
\-\ no\\:\\ 0\\.001291958184239943\ \(0\)\
\-\ with\\:\\ 0\\.0012297736225664088\ \(0\)\
